Search Results - Moro-Sibilot, Denis

Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer by Drilon, Alexander (Author) , Camidge, D. Ross (Author) , Lin, Jessica J. (Author) , Kim, Sang-We (Author) , Solomon, Benjamin J. (Author) , Dziadziuszko, Rafal (Author) , Besse, Benjamin (Author) , Goto, Koichi (Author) , Langen, Adrianus Johannes de (Author) , Wolf, Jürgen (Author) , Lee, Ki Hyeong (Author) , Popat, Sanjay (Author) , Springfeld, Christoph (Author) , Nagasaka, Misako (Author) , Felip, Enriqueta (Author) , Yang, Nong (Author) , Velcheti, Vamsidhar (Author) , Lu, Shun (Author) , Kao, Steven (Author) , Dooms, Christophe (Author) , Krebs, Matthew G. (Author) , Yao, Wenxiu (Author) , Beg, Muhammad Shaalan (Author) , Hu, Xiufeng (Author) , Moro-Sibilot, Denis (Author) , Cheema, Parneet (Author) , Stopatschinskaja, Shanna (Author) , Mehta, Minal (Author) , Trone, Denise (Author) , Graber, Armin (Author) , Sims, Gregory (Author) , Yuan, Yong (Author) , Cho, Byoung Chul (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext

A randomized-controlled phase 2 study of the MET antibody emibetuzumab in combination with erlotinib as first-line treatment for EGFR mutation-positive NSCLC patients by Scagliotti, Giorgio V. (Author) , Moro-Sibilot, Denis (Author) , Kollmeier, Jens (Author) , Favaretto, Adolfo (Author) , Cho, Eun Kyung (Author) , Grosch, Heidrun (Author) , Kimmich, Martin (Author) , Girard, Nicolas (Author) , Tsai, Chun-Ming (Author) , Hsia, Te-Chun (Author) , Brighenti, Matteo (Author) , Schumann, Christian (Author) , Wang, Xuejing Aimee (Author) , Wijayawardana, Sameera R. (Author) , Gruver, Aaron M. (Author) , Wallin, Johan (Author) , Mansouri, Kambiz (Author) , Wacheck, Volker (Author) , Chang, Gee-Chen (Author) ,

• Resolving-System, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext

Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study by Moro-Sibilot, Denis (Author) , Schnabel, Philipp Albert (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer by Shaw, Alice T. (Author) , Kim, Dong-Wan (Author) , Nakagawa, Kazuhiko (Author) , Seto, Takashi (Author) , Crinó, Lucio (Author) , Ahn, Myung-Ju (Author) , De Pas, Tommaso (Author) , Besse, Benjamin (Author) , Solomon, Benjamin J. (Author) , Blackhall, Fiona (Author) , Wu, Yi-Long (Author) , Thomas, Michael (Author) , O'Byrne, Kenneth J. (Author) , Moro-Sibilot, Denis (Author) , Camidge, D. Ross (Author) , Mok, Tony (Author) , Hirsh, Vera (Author) , Riely, Gregory J. (Author) , Iyer, Shrividya (Author) , Tassell, Vanessa (Author) , Polli, Anna (Author) , Wilner, Keith D. (Author) , Jänne, Pasi A. (Author) ,

• Verlag, lizenzpflichtig, Volltext